Retraction notice to "Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials" [Eur J Surg Oncol 40 (10) (October 2014) 1321-1330];Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials

European Journal of Surgical Oncology

Volumn 40, Issue 10, 2014, Pages 1321-1330

  Xiong, B ^a   Ma, L ^b   Cheng, Y ^a   Zhang, C ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Huaxi Hospital   (China)

Author keywords

Gastric cancer; Meta analysis; Neoadjuvant chemotherapy; Randomized controlled trial; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; STOMACH CANCER; SURVIVAL RATE; THROMBOCYTOPENIA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA; DISEASE FREE SURVIVAL; STOMACH NEOPLASMS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; NEOADJUVANT THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84925223762     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.05.001     Document Type: Erratum

References (29)

1. D.C. Katherine, and I.N. Alfred Epidemiology of gastric cancer World J Gastroenterol 12 2006 354 363
2. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. L. Yang Incidence and mortality of gastric cancer in China World J Gastroenterol 12 2006 17 20
4. J.J. Bonenkamp, J. Hermans, and M. Sasako et al. Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908 914
5. E. Frei 3rd Clinical cancer research: an embattled species Cancer 50 1982 1979 1992
6. H. Wilke, P. Preusser, and U. Fink et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin J Clin Oncol 7 1989 1318 1326
7. D. Cunningham, W.H. Allum, and S.P. Stenning et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
8. M. Ychou, V. Boige, and J.P. Pignon et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 2011 1715 1721
9. J.J. Qu, Y.R. Shi, and F.R. Liu et al. A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer Zhonghua Wei Chang Wai Ke Za Zhi 13 2010 664 667
10. R. Biffi, N. Fazio, and F. Luca et al. Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer World J Gastroenterol 16 2010 868 874
11. C. Schuhmacher, S. Gretschel, and F. Lordick et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954 J Clin Oncol 28 2010 5210 5218
12. H.H. Hartgrink, C.J. van de Velde, and H. Putter et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial Eur J Surg Oncol 30 2004 643 649
13. Y. Nio, M. Koike, and H. Omori et al. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer - a single institute study Anticancer Res 24 2004 1879 1887
14. X.L. Wang, G.X. Wu, and M.D. Zhang et al. A favorable impact of preoperative FPLC chemotherapy on patients with gastric cardia cancer Oncol Rep 7 2000 241 244
15. T. Kobayashi, and T. Kimura Long-term outcome of preoperative chemotherapy with 5′-deoxy-5-fluorouridine (5′-DFUR) for gastric cancer Gan To Kagaku Ryoho 27 2000 1521 1526
16. N.J. Lygidakis, G. Sgourakis, and P. Aphinives Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial Hepatogastroenterology 46 1999 2035 2038
17. Y.K. Kang, D.W. Choi, and Y.H. Im et al. A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer Abstract 503 presented at the ASCO annual meeting 1996 Available from: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst-detail-view&confID=29&abstractID=10042
18. Y. Yonemura, T. Sawa, and K. Kinoshita et al. Neoadjuvant chemotherapy for high-grade advanced gastric cancer World J Surg 17 1993 256 261 [discussion 261-262]
19. A.W. Wu, G.W. Xu, and H.Y. Wang et al. Neoadjuvant chemotherapy versus none for resectable gastric cancer Cochrane Database Syst Rev 18 2007 CD005047
20. L.F. He, K.H. Yang, and J.H. Tian et al. Meta analysis of clinical effectiveness of neoadjuvant chemotherapy for gastric cancer Ai Zheng 27 2008 407 412
21. W. Li, J. Qin, and Y.H. Sun et al. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis World J Gastroenterol 16 2010 5621 5628
22. A.R. Jadad, R.A. Moore, and D. Carroll et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
23. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions, version 5.0.1 [Updated September 2008] 2008 The Cochrane Collaboration Available from: http://www.cochrane-handbook.org
24. R.R. MacLehose, B.C. Reeves, and I.M. Harvey et al. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies Health Technol Assess 4 2000 1 154
25. M. Moehler, O. Lyros, and I. Gockel et al. Multidisciplinary management of gastric and gastroesophageal cancers World J Gastroenterol 14 2008 3773 3780
26. J. Sastre, J.A. Garcia-Saenz, and E. Diaz-Rubio Chemotherapy for gastric cancer World J Gastroenterol 12 2006 204 213
27. K. Ng, J.A. Meyerhardt, and C.S. Fuchs Adjuvant and neoadjuvant approaches in gastric cancer Cancer J 13 2007 168 174
28. V. Valenti, J.L. Hernandez-Lizoaín, and M.C. Beorlegui et al. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy J Surg Oncol 104 2011 124 129
29. S.S. Wohrer, M. Raderer, and M. Hejna Palliative chemotherapy for advanced gastric cancer Ann Oncol 15 2004 1585 1595